Market revenue in 2023 | USD 0.6 million |
Market revenue in 2030 | USD 1.2 million |
Growth rate | 12.3% (CAGR from 2023 to 2030) |
Largest segment | Neurology |
Fastest growing segment | Neurology |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Dental, Orthopedic, Neurology |
Key market players worldwide | GlaxoSmithKline, Hewlett Packard Enterprise Co, Merck KGaA, AstraZeneca PLC, Aprecia Pharmaceuticals, Extend Biosciences, BioDuro, Affini-T Therapeutics, Osmotica Pharmaceutical, FabRx, Cycle Pharmaceuticals |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to 3d printed drugs market will help companies and investors design strategic landscapes.
Neurology was the largest segment with a revenue share of 50% in 2023. Horizon Databook has segmented the UAE 3d printed drugs market based on dental, orthopedic, neurology covering the revenue growth of each sub-segment from 2018 to 2030.
The UAE is making substantial investments in technology to improve the quality of life and nurture emerging industries. Governments across the region are committing significant resources to R&D, especially in cutting-edge digital technologies, with the primary aim of diversifying economies and reducing reliance on fossil fuels.
In 2016, Dubai initiated its 3D printing strategy. This comprehensive strategy introduced a multifaceted plan to position the UAE as a global leader in 3D printing technology. The government aims to establish Dubai and the UAE as global hubs for 3D printing technology by 2030.
In July 2020, the Crown Prince of Dubai inaugurated the 3D Printing Strategic Alliance. This pioneering initiative aims to create a comprehensive network involving government entities, educational institutions, and 3D printing companies in the UAE and across the globe.
Horizon Databook provides a detailed overview of country-level data and insights on the UAE 3d printed drugs market , including forecasts for subscribers. This country databook contains high-level insights into UAE 3d printed drugs market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account